Lawyers and Settlements
Advertisement
Home Page >> Legal News Articles >> Defective Products

Legal News Articles - Defective Products

Propecia Infertility: Kids Don’t Care if You’re Bald

Propecia Infertility: Kids Don’t Care if You’re Bald January 7, 2017. By Jane Mundy.
Ottawa, ON: Infertility is typically considered a woman’s issue, but three out of 10 cases of infertility are due to problems deriving from the man, according to statistics from Canada’s federal government. Many factors can contribute to male infertility, including Propecia, which is known to affect sperm quality.
Read [ Propecia Infertility: Kids Don’t Care if You’re Bald ]

Number of Consolidated Taxotere Lawsuits Jumps

Number of Consolidated Taxotere Lawsuits Jumps January 6, 2017. By Heidi Turner.
New Orleans, LA: It's only been three months since the Judicial Panel on Multidistrict Litigation (JPML) consolidated the federal Taxotere lawsuits, but in that time the number of Taxotere claims added to the multidistrict litigation (MDL) has increased dramatically, a sign that women are unhappy about allegedly being put at an increased risk of side effects. Sanofi SA faces allegations it failed to adequately warn women that the hair loss they experienced as a result of the cancer treatment drug could be permanent.
Read [ Number of Consolidated Taxotere Lawsuits Jumps ]

$13.7M Ethicon Vaginal Mesh Award Should Stand

$13.7M Ethicon Vaginal Mesh Award Should Stand January 6, 2017. By Lucy Campbell.
Santa Clara, CA: A $13.7 million judgement in favor of a plaintiff who has sued Johnson & Johnson’s subsidiary Ethicon, over injuries related to Ethicon's mid-urethral sling device, should not be reversed on appeal. That’s the opinion of Philadelphia Court of Common Pleas Judge Kenneth J. Powell Jr., who is presiding over the case and who wrote "The evidence of defendant-appellant's wanton and willful disregard for plaintiff adequately supported the jury's award of punitive damages."
Read [ $13.7M Ethicon Vaginal Mesh Award Should Stand ]

First Xarelto Bellwether Trial Due in March, Others to Follow in 2017

First Xarelto Bellwether Trial Due in March, Others to Follow in 2017 January 6, 2017. By Gordon Gibb.
Orleans, LA: The massive Xarelto lawsuit portfolio, currently with almost 14,000 cases pending in multidistrict litigation, will see its first bellwether trial roll out in March with additional bellwethers slated for April and May. Plaintiffs allege that Xarelto, a blood thinner, triggered Xarelto bleeding complications without benefit of an available antidote to reverse the blood thinning properties of the anticoagulant.
Read [ First Xarelto Bellwether Trial Due in March, Others to Follow in 2017 ]

2017 Expected to be a Landmark Year for Airbag Injury Litigation

2017 Expected to be a Landmark Year for Airbag Injury Litigation January 6, 2017. By Gordon Gibb.
Washington, DC: 2017 is shaping up to be a landmark year for Takata Corp. and lawsuits alleging airbag injuries. The sheer magnitude of the defective airbags recall, the unavailability of replacement parts and Takata’s financial health (reported to be tenuous), combines to create a portfolio of interest likely to wane little as the year unfolds.
Read [ 2017 Expected to be a Landmark Year for Airbag Injury Litigation ]

J&J’s Cost of Defending its Talcum Powder is Rising

J&J’s Cost of Defending its Talcum Powder is Rising January 6, 2017. By Jane Mundy.
St. Louis, MO: Johnson & Johnson last year was hit with three talcum powder cancer lawsuits, making the jury verdicts in St. Louis a combined $197 million. Judging from the drug company’s continued legal woes, it appears that these settlements may simply be the cost of doing business. 
Read [ J&J’s Cost of Defending its Talcum Powder is Rising ]

Pradaxa Lawsuits Allege Pradaxa Bleeding Risk, Insufficient Warnings

Pradaxa Lawsuits Allege Pradaxa Bleeding Risk, Insufficient Warnings January 4, 2017. By Gordon Gibb.
Hartford, CT: Even though Pradaxa and a competitor were brought to market as an easier-to-manage alternative to warfarin, previously the gold standard for blood thinning, no one disputes the fact that all anti-coagulants carry a risk for bleeding events. However, it is alleged in Pradaxa lawsuits that some blood thinners carry a greater risk for bleeding events than others.
Read [ Pradaxa Lawsuits Allege Pradaxa Bleeding Risk, Insufficient Warnings ]

Story of Failed DePuy Hip Replacement Devices “Shocking” says Lawyer

Story of Failed DePuy Hip Replacement Devices “Shocking” says Lawyer January 4, 2017. By Brenda Craig.
New York, NY Truth remains supreme in the courtrooms of America and the facts revealed in the recent litigation against Johnson & Johnson and its subsidiary DePuy Orthopaedics Inc. tell a “shocking” story of “fraud and conspiracy”, says attorney Jayne Conroy from the firm of Simmons Hanly Conroy of New York.
Read [ Story of Failed DePuy Hip Replacement Devices “Shocking” says Lawyer ]

Alere Inc. In Tough over Recalled INRatio, Abbott Merger in Jeopardy

Alere Inc. In Tough over Recalled INRatio, Abbott Merger in Jeopardy January 3, 2017. By Gordon Gibb.
Georgetown, DE: An Alere lawsuit filed by former suitor Abbott Laboratories Inc. (Abbott) over a proposed merger is, for the moment, redirecting attention away from the failed INRatio measuring device that was recalled in July. The recalled product nonetheless has a role in the recent performance of Alere Inc. (Alere) that has prompted Abbott to back away. This, in spite of recent assurances from the US Food and Drug Administration (FDA) that any failings of the Alere INRatio device had no bearing on the relationship between warfarin (Coumadin) and Xarelto (rivaroxaban), and the subsequent approval of the latter.
Read [ Alere Inc. In Tough over Recalled INRatio, Abbott Merger in Jeopardy ]

More Evidence Linking Monsanto’s Roundup to Cancer

More Evidence Linking Monsanto’s Roundup to Cancer January 2, 2017. By Jane Mundy.
Los Angeles, CA:In the wake of recent research, more lawsuits are being filed against Monsanto claiming its weedkiller Roundup causes cancer. And California’s Office of Environmental Health Hazard Assessment (OEHHA) has likely added one more nail to Roundup’s coffin.
Read [ More Evidence Linking Monsanto’s Roundup to Cancer ]

Page: 1  -  8  9  10  11  12  13  14  -  10»  -  42   Next»